Physicochemical characterization of phosphinic pseudopeptides by capillary zone electrophoresis in highly acidic background electrolytes
Language English Country Germany Media print
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Electrophoresis, Capillary methods standards MeSH
- Electrolytes chemistry MeSH
- Hydrogen-Ion Concentration MeSH
- Dichloroacetic Acid MeSH
- Oxalic Acid MeSH
- Phosphinic Acids chemistry MeSH
- Phosphoric Acids MeSH
- Mathematics MeSH
- Molecular Structure MeSH
- Osmolar Concentration MeSH
- Peptides analysis chemistry MeSH
- Buffers MeSH
- Temperature MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- Electrolytes MeSH
- Dichloroacetic Acid MeSH
- Oxalic Acid MeSH
- Phosphinic Acids MeSH
- Phosphoric Acids MeSH
- Peptides MeSH
- phosphoric acid MeSH Browser
- Buffers MeSH
Phosphinic pseudopeptides (i.e., peptide isosteres with one peptide bond replaced by a phosphinic acid moiety) were analyzed and physicochemically characterized by capillary zone electrophoresis in the pH range of 1.1-3.2, employing phosphoric, phosphinic, oxalic and dichloroacetic acids as background electrolyte (BGE) constituents. The acid dissociation constant (pK(a)) of phosphinate group in phosphinic pseudopeptides and ionic mobilities of these analytes were determined from the pH dependence of their effective electrophoretic mobilities corrected to standard temperature and constant ionic strength of the BGEs. It was shown that these corrections are necessary whenever precise mobility data at very low pH are to be determined. Additionally, it was found that the ionic mobilities of the phosphinic pseudopeptides and pK(a) of their phosphinate group are affected by the BGE constituent used. The variability of migration behavior of the pseudopeptides can be attributed to their ion-pairing formation with the BGE components.
References provided by Crossref.org
Structure-activity study of new inhibitors of human betaine-homocysteine S-methyltransferase